MANDREA KEARNEY: Open Payments
NPI 1669016507 · CALHOUN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 85 payments from 15 companies in 2025. Trend: 2023 $907 · 2024 $1,114 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $321 |
| PFIZER INC. | 11 | $197 |
| Novo Nordisk Inc | 10 | $189 |
| Lilly USA, LLC | 5 | $101 |
| GlaxoSmithKline, LLC. | 5 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Axsome Therapeutics, Inc. | 2 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Amgen Inc. | 3 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
Products named: VRAYLAR, QULIPTA, Ozempic, NURTEC ODT, TRELEGY ELLIPTA, PREVNAR 20, UBRELVY, Wegovy.
Industry payments across GA — which companies pay providers there.
